Dudediligence.

Relay Therapeutics, Inc

RLAYNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$141.2M

15 notices · 7,029,736 sh

Oct 2025 to Oct 2026

Reported ·

$129.0M

38 sales · 0 buys

Oct 2025 to Sep 2026

The two figures cover different periods.

19 of 38 reported sales carry the 10b5-1 box. Together they are 3.13% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Sep 2026N2025DJ2026FMAMJJASO2026-10-07: SANJIV PATEL, Form 1442026-10-06: THOMAS CATINAZZO, Form 1442026-08-26: PETER RAHMER, Form 1442026-08-25: SVF Pauling (Cayman) Ltd, Form 1442026-08-04: SEKAR KATHIRESAN, Form 1442026-07-31: SEKAR KATHIRESAN, Form 1442026-07-21: SEKAR KATHIRESAN, Form 1442026-07-20: SEKAR KATHIRESAN, Form 1442026-07-07: SANJIV PATEL, Form 1442026-06-30: PETER RAHMER, Form 1442026-06-22: DONALD BERGSTROM, Form 1442026-06-22: THOMAS CATINAZZO, Form 1442026-05-14: THOMAS CATINAZZO, Form 1442026-03-09: THOMAS CATINAZZO, Form 1442025-10-29: Peter J Rahmer, Form 1442025-10-28: Bergstrom Donald A, sold2025-10-28: Catinazzo Thomas, sold2025-10-28: Rahmer Peter, sold2025-11-03: Patel Sanjiv, sold2026-01-06: Patel Sanjiv, sold2026-01-27: Catinazzo Thomas, sold2026-01-27: Rahmer Peter, sold2026-01-27: Bergstrom Donald A, sold2026-03-09: Catinazzo Thomas, sold2026-04-07: Catinazzo Thomas, sold2026-04-28: Bergstrom Donald A, sold2026-04-28: Rahmer Peter, sold2026-04-28: Catinazzo Thomas, sold2026-05-14: Catinazzo Thomas, sold2026-06-22: Bergstrom Donald A, sold2026-06-22: Catinazzo Thomas, sold2026-06-30: Rahmer Peter, sold2026-07-06: Catinazzo Thomas, sold2026-07-06: Bergstrom Donald A, sold2026-07-07: Patel Sanjiv, sold2026-07-28: Bergstrom Donald A, sold2026-07-28: Rahmer Peter, sold2026-07-28: Catinazzo Thomas, sold2026-08-14: Catinazzo Thomas, sold2026-08-17: Patel Sanjiv, sold2026-08-25: SB INVESTMENT ADVISERS (UK) LTD, sold2026-08-26: Rahmer Peter, sold2026-09-08: Patel Sanjiv, sold2026-09-08: Catinazzo Thomas, sold2026-09-08: Bergstrom Donald A, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-10-07SANJIV PATEL, President and CEO$1,806,555
96,401 shplan 2025-10-30Form 4s on file end Sep 23144 ↗
2026-10-06THOMAS CATINAZZO, Chief Financial Officer$1,806,237
93,153 shplan 2025-10-30Form 4s on file end Sep 23144 ↗
2026-08-26PETER RAHMER, See remarks$1,028,500
50,000 shplan 2025-10-31144 ↗
Form 4, 2026-08-28: sold 4,508 at $20.03 Form 4 ↗
2026-08-25SVF Pauling (Cayman) Ltd, Stockholder$123.4M
6,000,000 shno plan date144 ↗
Form 4, 2026-08-28: sold 6,000,000 at $19.40 Form 4 ↗
2026-08-04SEKAR KATHIRESAN, Director$826,466
42,225 shno plan dateForm 4s on file end Sep 23144 ↗
2026-07-31SEKAR KATHIRESAN, Director$563,553
30,000 shno plan dateForm 4s on file end Sep 23144 ↗
2026-07-21SEKAR KATHIRESAN, Director$594,414
30,000 shno plan dateForm 4s on file end Sep 23144 ↗
2026-07-20SEKAR KATHIRESAN, Director$1,293,555
66,055 shno plan dateForm 4s on file end Sep 23144 ↗
2026-07-07SANJIV PATEL, President and CEO$2,732,883
144,597 shplan 2025-10-30144 ↗
Form 4, 2026-07-08: sold 48,199 at $19.58 Form 4 ↗
2026-06-30PETER RAHMER, See remarks$987,000
50,000 shplan 2025-10-31144 ↗
Form 4, 2026-07-02: sold 50,000 at $19.09 Form 4 ↗
2026-06-22DONALD BERGSTROM, President, R&D$1,757,058
110,646 shplan 2025-10-30144 ↗
Form 4, 2026-06-24: sold 93,456 at $16.94 Form 4 ↗
2026-06-22THOMAS CATINAZZO, Chief Financial Officer$3,253,494
204,880 shplan 2025-10-30144 ↗
Form 4, 2026-06-24: sold 187,163 at $16.97 Form 4 ↗
2026-05-14THOMAS CATINAZZO, Chief Financial Officer$492,233
37,234 shplan 2025-10-30144 ↗
Form 4, 2026-05-14: sold 17,717 at $12.86 Form 4 ↗
2026-03-09THOMAS CATINAZZO, Chief Financial Officer$525,663
53,151 shplan 2025-10-30144 ↗
Form 4, 2026-03-11: sold 17,717 at $10.06 Form 4 ↗
2025-10-29Peter J Rahmer, See remarks$160,436
21,394 shno plan date144 ↗
Form 4, 2025-10-30: sold 40,529 at $7.40 Form 4 ↗